High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
4.60B
+9.11%
2.331
+14.84%
4.74B
+9.86%
2.355
+8.03%
4.93B
+9.81%
2.420
+8.52%
Estimates Revision
The market is revising Downward the revenue expectations for XP Inc. (XP) for FY2025, with the revenue forecasts being adjusted by -0.74% over the past three months. During the same period, the stock price has changed by 23.69%.
Revenue Estimates for FY2025
Revise Downward
-0.74%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+0.59%
In Past 3 Month
Stock Price
Go Up
+23.69%
In Past 3 Month
6 Analyst Rating
0Wall Street analysts forecast XP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XP is 22.17 USD with a low forecast of 19.00 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
2 Hold
0 Sell
Moderate Buy
0Current: 17.180
Low
19.00
Averages
22.17
High
24.00
0Current: 17.180
Low
19.00
Averages
22.17
High
24.00
Itau BBA
Outperform -> Market Perform
downgrade
$21
2025-06-22
Reason
Itau BBA
Price Target
$21
2025-06-22
downgrade
Outperform -> Market Perform
Reason
Itau BBA downgraded XP Inc. to Market Perform from Outperform with a $21 price target.
UBS
Buy
maintain
$17 -> $24
2025-06-10
Reason
UBS
Price Target
$17 -> $24
2025-06-10
maintain
Buy
Reason
UBS raised the firm's price target on XP Inc. to $24 from $17 and keeps a Buy rating on the shares.
Goldman Sachs
Tito Labarta
Neutral -> Buy
upgrade
$17 -> $23
2025-06-04
Reason
Goldman Sachs
Tito Labarta
Price Target
$17 -> $23
2025-06-04
upgrade
Neutral -> Buy
Reason
Grupo Santander
Neutral -> Outperform
upgrade
$22
2025-05-28
Reason
Grupo Santander
Price Target
$22
2025-05-28
upgrade
Neutral -> Outperform
Reason
Grupo Santander upgraded XP Inc. to Outperform from Neutral with a $22 price target. The company has exposure to Brazil's better capital market trends, the analyst tells investors in a research note.
BofA
Mario Pierry
Neutral
maintain
$16 -> $19
2025-05-21
Reason
BofA
Mario Pierry
Price Target
$16 -> $19
2025-05-21
maintain
Neutral
Reason
Morgan Stanley
Equal Weight -> Overweight
upgrade
$18 -> $24
2025-05-12
Reason
Morgan Stanley
Price Target
$18 -> $24
2025-05-12
upgrade
Equal Weight -> Overweight
Reason
Morgan Stanley upgraded XP Inc. to Overweight from Equal Weight with a price target of $24, up from $18 as part of a broader research note on Brazil Financial Institutions. The stock offers leveraged exposure to rising equity trading volumes and capital markets recovery, the analyst tells investors in a research note. XP also stands to benefit from two key effects of falling rates - portfolio rotation and renewed investor confidence, the firm added.
See All Ratings
Valuation Metrics
The current forward P/E ratio for XP Inc (XP.O) is 10.56, compared to its 5-year average forward P/E of 21.42. For a more detailed relative valuation and DCF analysis to assess XP Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
21.42
Current PE
10.56
Overvalued PE
36.04
Undervalued PE
6.80
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
Undervalued EV/EBITDA
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
5.56
Current PS
2.80
Overvalued PS
9.12
Undervalued PS
1.99
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 288.8% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
XP News & Events
Events Timeline
(ET)
2025-07-09
09:41:58
XP Inc. files federal lawsuit against Grizzly Research
2025-05-20 (ET)
2025-05-20
16:23:49
XP Inc. reports Q1 net income R$1.24B vs. R$1.03B last year
2025-05-20
16:21:12
XP Inc. announces new share buyback program for up to R$1.0B
Sign Up For More Events
Sign Up For More Events
News
Preview
7.0
07-08ReutersBrazil's XP sues short seller Grizzly Research in New York, alleges defamation
Preview
6.5
06-27NASDAQ.COMAnalysts Anticipate 10% Upside For IWR
Preview
6.0
06-11NASDAQ.COMNew Analyst Forecast: $XP Given 'Buy' Rating
Sign Up For More News
People Also Watch
FAQ
What is XP Inc (XP) stock price today?
What is XP Inc (XP)'s business?
What is the price predicton of XP Stock?
What is XP Inc (XP)'s revenue for the last quarter?
What is XP Inc (XP)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for XP Inc (XP)'s fundamentals?
How many employees does XP Inc (XP). have?